Follow
Mimansa Goyal
Mimansa Goyal
PhD. in Pharmaceutical Sciences
Verified email at stjohns.edu
Title
Cited by
Cited by
Year
Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes
NKK Vineela Parvathaneni, Rasha S. Elbatanony, Mimansa Goyal, Tejashri ...
International Journal of Molecular Sciences 22 (9), 4783, 2021
282021
Development of gelatin methacrylate (GelMa) hydrogels for versatile intracavitary applications
NS Kulkarni, G Chauhan, M Goyal, S Sarvepalli, V Gupta
Biomaterials Science 10 (16), 4492-4507, 2022
242022
Cationically modified inhalable nintedanib niosomes: enhancing therapeutic activity against non-small-cell lung cancer
S K Shukla, V Nguyen, M Goyal, V Gupta
Nanomedicine 17 (13), 935-958, 2022
212022
Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC)
VG Vineela Parvathaneni, Mimansa Goyal
American Journal of Respiratory and Critical Care Medicine, 2019
21*2019
Small-molecule Gankyrin inhibition as a therapeutic strategy for breast and lung cancer
D Kanabar, M Goyal, EI Kane, T Chavan, A Kabir, X Wang, S Shukla, ...
Journal of medicinal chemistry 65 (13), 8975-8997, 2022
82022
Poly vinyl pyrrolidone (PVP) based inhaled delivery carriers for olaparib for non-small cell lung cancer (NSCLC) treatment
M Goyal, G Tulsyan, DD Kanabar, T Chavan, A Muth, V Gupta
Journal of Drug Delivery Science and Technology 87, 104767, 2023
52023
A Nanoemulgel for Nose-to-Brain delivery of Quetiapine–QbD-Enabled formulation development & in-vitro characterization
D Gadhave, M Quadros, AR Ugale, M Goyal, V Gupta
International Journal of Pharmaceutics 648, 123566, 2023
42023
Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine–Development & characterization in physiologically relevant 3D tissue models
DG Gadhave, M Quadros, AR Ugale, M Goyal, S Ayehunie, V Gupta
International Journal of Biological Macromolecules 267, 131491, 2024
22024
Inhaled nintedanib nanoparticles for enhanced efficacy in idiopathic pulmonary fibrosis (IPF) treatment–Evidence in disease-relevant in-vitro models
X Wang, M Goyal, D Gadhave, V Gupta
Journal of Drug Delivery Science and Technology 95, 105615, 2024
22024
Excipients for Novel Inhaled Dosage Forms: An Overview
C Yousry, M Goyal, V Gupta
AAPS PharmSciTech 25 (2), 36, 2024
12024
Continuously producible aztreonam-loaded inhalable lipid nanoparticles for cystic fibrosis-associated Pseudomonas aeruginosa infections–Development and in-vitro characterization
G Chauhan, AA Shaik, SS Sawant, R Diwan, M Mokashi, M Goyal, ...
Biomaterials Advances 166, 214027, 2025
2025
Exploring the enhanced stability and therapeutic efficacy of Sorafenib-Cyclodextrin inclusion complex
SK Shukla, M Goyal, DD Kanabar, S Ayehunie, B Deore, CA Sanhueza, ...
Journal of Molecular Liquids 401, 124701, 2024
2024
Synthesis and evaluation of 2, 5-substituted pyrimidines as small-molecule gankyrin binders
D Kanabar, EI Kane, T Chavan, TM Laflamme, E Suarez, M Goyal, ...
Future Medicinal Chemistry 16 (3), 239-251, 2024
2024
Approaches for drug delivery to the mitochondria: current status and future trends
M Goyal, V Parvathaneni, V Gupta
Multifunctional Nanocarriers, 261-288, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–14